Welcome to our dedicated page for Danimer Scientific news (Ticker: DNMR), a resource for investors and traders seeking the latest updates and insights on Danimer Scientific stock.
Danimer Scientific, Inc. (DNMR) is a leading innovator in the bioplastics industry, specializing in the production of sustainable and renewable biopolymers. Located in Bainbridge, Georgia, Danimer is at the forefront of developing biodegradable and compostable polymers, notably Polyhydroxyalkanoates (PHA) under the proprietary brand name, Nodax.
This innovative company transforms natural, renewable resources, such as cold-pressed canola oil, into high-performance bioplastics. These bioplastics match or surpass the quality and cost-effectiveness of traditional petroleum-based plastics, offering a greener alternative that reduces environmental impact.
Danimer's products are capable of biodegrading in environments such as soil, freshwater, and marine waters, thereby helping to combat plastic pollution. The company's technology is utilized in a broad range of applications, including additives, aqueous coatings, fibers, filaments, films, and injection-molded articles.
Beyond its core business of biopolymer production, Danimer also provides specialty toll manufacturing services. This includes access to state-of-the-art production equipment, advanced laboratories, comprehensive material handling and logistics, and a team of experienced, trained personnel.
The company's operations are not confined to the United States, although it remains the primary market. Danimer also has a significant presence in Europe, including Germany, Poland, and Belgium.
Danimer's continuous efforts in innovation and sustainability have earned it numerous partnerships with global brands looking to incorporate environmentally responsible materials into their products. With a commitment to reducing the world's reliance on non-renewable resources, Danimer is paving the way towards a more sustainable future.
Danimer Scientific, Inc. (NYSE: DNMR) reported its Q2 2022 financial results, showing revenues of $12.7 million, an 85% increase in PHA-based product sales. However, the company faced a net loss of $30.4 million, coupled with decreased gross profit of $(2.2) million. Adjusted EBITDA also worsened to $(12.9) million from $(2.7) million year-over-year. Danimer maintained a cash balance of $140.4 million and total debt of $264.3 million. Looking ahead, it reaffirms its Adjusted EBITDA outlook for 2022 between $(45) million and $(35) million.
Danimer Scientific (NYSE: DNMR) will announce its second quarter 2022 financial results on August 9, 2022, following market closure. A conference call and webcast will take place at 5:00 p.m. Eastern time to discuss these results and related events. The live presentation will be available on the Company's Investor Relations website, with a replay accessible afterward. Danimer specializes in biodegradable materials, holding over 430 patents globally. The Company remains focused on sustainable biopolymer innovations.
Danimer Scientific (NYSE: DNMR) has been invited to submit a Part II application for a loan guarantee under the U.S. Department of Energy's Title XVII Loan Guarantee Program. This invitation indicates that the project meets technical eligibility requirements. If successful, the funding will support Danimer's Greenfield expansion in Bainbridge and a new plant in the Gulf States region. However, the company warns that there is no guarantee of receiving the loan guarantee, as it depends on the DOE's further evaluation and negotiation process.
Danimer Scientific, Inc. (NYSE: DNMR) reported a 12% increase in total revenues for Q1 2022, reaching $14.7 million, driven by nearly doubling PHA-based product sales. However, gross profit dipped to $(1.3) million from $1.5 million a year earlier. Adjusted EBITDA fell to $(10.6) million due to increased operating costs and R&D expenses. The company projects a challenging year ahead with an expected Adjusted EBITDA range of $(45) million to $(35) million for 2022. Despite these hurdles, Danimer remains focused on scaling production and improving profitability from PHA-based products.
Danimer Scientific (NYSE: DNMR) and Kemira have announced a multi-year license and supply agreement to commercialize biobased barrier coatings for paper and board products. This agreement expands their previous collaboration and targets food and beverage applications across North America, South America, Europe, the Middle East, and Africa. The dispersion barrier market, currently valued at
Danimer Scientific (NYSE: DNMR) will release its Q1 2022 financial results on May 10, 2022, after market close. A conference call is scheduled for 5:00 p.m. Eastern time that same day to discuss the results and recent events. The call will be accessible via the Company’s Investor Relations website or by phone. Danimer is known for creating biodegradable materials and holds over 430 patents in this field. The company emphasizes its commitment to sustainability and innovative bioplastics.
Danimer Scientific (NYSE: DNMR) has appointed Anthony Austin as Chief Human Resource Officer, bringing over 30 years of HR experience from industry giants like PepsiCo and Delta Air Lines. His role will emphasize developing HR processes to support Danimer's growth and expanding manufacturing capacity. Austin's previous position at Bedrock Manufacturing Co. involved leadership in HR strategy and talent management. CEO Stephen E. Croskrey highlighted Austin's expertise as pivotal for scaling operations in response to increasing demand for biodegradable materials.
Danimer Scientific (NYSE: DNMR) reported preliminary financial results for Q4 and 2021, highlighting a 47% revenue increase to $17.7 million in Q4, driven by PHA product sales which grew significantly. However, the company faced a net loss of $12.4 million in Q4, influenced by a $21.3 million non-cash gain from warrant remeasurement. Full year revenues reached $58.7 million, with a net loss of $60.1 million. Management anticipates improved production efficiencies in 2022, especially at its Kentucky facility, which should enhance EBITDA performance moving forward.
Danimer Scientific (NYSE: DNMR) has appointed Keith A. Edwards as Vice President of Business Development. With over 30 years in the polymer industry, including leadership roles at BASF and Chevron Phillips Chemical, Edwards aims to expand Danimer's biodegradable alternatives to traditional plastics. Stephen E. Croskrey, CEO, expressed confidence in Edwards’ ability to enhance market opportunities as Danimer grows its manufacturing capacity. Edwards emphasized the potential for collaboration in sustainable solutions for single-use plastics.
FAQ
What is the current stock price of Danimer Scientific (DNMR)?
What is the market cap of Danimer Scientific (DNMR)?
What does Danimer Scientific, Inc. do?
Where is Danimer Scientific located?
What are Danimer Scientific's bioplastics made from?
What are the applications of Danimer's biopolymers?
Are Danimer's products biodegradable?
Does Danimer Scientific operate internationally?
What is the Nodax brand?
What additional services does Danimer offer?
Who are Danimer's customers?
What makes Danimer’s bioplastics cost-effective?
